MULTIPLE MYELOMA PATIENTS THAT DEVELOP SECOND PRIMARY MALIGNANCY HAVE A WORSE PROGNOSIS THAN MULTIPLE MYELOMA PATIENTS TREATED BEFORE THE INTRODUCTION OF NOVEL AGENTS: A POPULATION BASED-STUDY
| Autor: | Jonsdottir, G., Sigrún Helga Lund, Landgren, O., Bjorkholm, M., Turesson, I., Wahlin, A., Blimark, C., Hultcrantz, M., Porwit, A., Kristinsson, S. Y. |
|---|---|
| Zdroj: | Publons ResearcherID |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|